Supernus Pharmaceuticals IncAdd to My Watchlist

SUPN:USNASDAQ GMIndustry: Medical-Drugs
  • 8.94
    Last
  • 0.24  -2.61%
    Today's Change
  • 9.18
    Previous Close
  • Today
     
    5.84
    11.47
    52 Week Low - High
8:10 pm ET 7/25/2014
Intraday data is at least 15 minutes delayed; All prices are in the local currency; Time is ET.
Stock Price Details
Shares Outstanding42 million
Market Cap$376 million
Return on Equity ttm-254.40%
Last DividendSUPN:US does not pay a dividend
Earnings
EPS: Year Actual ttm-1.972
EPS: Year Est. 12/14 ttm-0.722
 
EPS: Quarterly Actual 3/14 -0.36
EPS: Quarterly Est. 6/14 -0.22
 
Price/Earnings ttm--
Relative Price/Earnings--
Earnings Growth Rate-6.62
Company Description
Supernus Pharmaceuticals Inc. is a specialty pharmaceutical company. The Company develops and markets proprietary drugs for the treatment of central nervous system diseases and disorders. Supernus has developed a portfolio of clinical stage drugs to address neurological and psychological problems such as epilepsy, conduct disorder, Parkinson's disease, ADHD, depression and anxiety.
Revenue$12 million
Net Income$-92 million
Total Assets$111 million
Employees235
Web Sitewww.supernus.com

Latest Headlines

No news available.

    Watchlist

    Unless indicated otherwise: intraday data is at least 15 minutes delayed; mutual fund NAVs are updated at the close of every market day; all prices are in the local currency; Time is ET.

    Sign In Now

     

    Not Registered?

    Get complete access to The Washington Post online - it's FREE!